Skip to main content
. 2021 May 14;9:e11422. doi: 10.7717/peerj.11422

Figure 5. Correlation analysis with clinicopathologic characteristics of PLOD1 in glioma.

Figure 5

(A) Age (<42, n = 294; ≥ 42, n = 342), (B) grade (WHO II, n = 164; WHO III, n = 207; WHO IV, n = 265), (C) PRS type (Primary, n = 433; Recurrent, n = 179; Secondary, n = 24), (D) 1p19q codeletion status (Codel, n = 126; Non-codel, n = 510), and (E) IDH mutation status (Mutant, n = 347; Wildtype, n = 289).